Revolutionizing Molecular Biology: Telomerase, Aging, and Cancer
Nobel laureate Elizabeth Blackburn has made groundbreaking contributions to molecular biology, particularly through her co-discovery of the telomerase enzyme in 1984. This pivotal finding revolutionized our understanding of cellular aging and the development of cancer, leading to her shared Nobel Prize in Physiology or Medicine in 2009. Blackburn and her research team at UCSF continue their groundbreaking work on telomerase and telomere biology, focusing on various cell types, including human cells. As a prominent figure in the scientific community and a staunch advocate for gender equality, Blackburn will also share her personal career journey and provide practical advice for overcoming challenges and biases while promoting a more equitable scientific landscape. She initiated the "Lindau guidelines" for scientific research and conduct that will support global, sustainable and cooperative open science in the long-term.
Born in Australia, Elizabeth Blackburn obtained her B.Sc. and M.Sc. degrees from the University of Melbourne, followed by a Ph.D. from the University of Cambridge in England. After her postdoctoral fellowship at Yale University Blackburn joined the faculty of the University of California, Berkeley, in 1978. In 1990, she moved across the San Francisco Bay to UCSF where she became a Professor Emeritus at the end of 2015.